Medbroadcast  Powered by MediResource
 Search

Go
 Browse alphabetically
ABCDEFGHIJKLMN
OPQRSTUVWXYZ
HEALTH TOPICS
Family & Child Health
Men's Health
Women's Health
Seniors' Health
Addiction
Allergy
Ankylosing Spondylitis
Arthritis (Rheumatoid)
Asthma
Atrial Fibrillation
Baby Health
Back Health
Bedwetting
Bladder (Overactive)
Brain Health
Cancer
Childhood Vaccinations
Cholesterol
Crohn's & Colitis
Cold and Flu
COPD NEW!
Cosmetic Procedures
Depression NEW!
Diabetes
Digestive Health
Ear Health
Eating Disorders
Eye Health
Flu (Seasonal)
Fertility
Fitness
Healthy Skin
Heart
High Blood Pressure
HPV
Hyperhidrosis
Incontinence
Infection
Kidney Health
Lung Health
Medications and your Health
Menopause
Mental Health
Multiple Sclerosis NEW!
Natural and Complementary Therapy
Nutrition
Obesity
Oral Care
Osteoarthritis of the Knee NEW!
Pain
Pregnancy
Psoriasis
Psoriatic Arthritis (PsA)
Seasonal Health
Sexual Health
Sleep Health
Stroke Risk Reduction
Smoking
Weight Management
Workplace Health
Yeast Infection
All health channels

STAY CONNECTED
RESOURCES
Ask an Expert
Clinical Trials
Find a Specialist
Health features
News
Tools


Condition Info Drug Info Tests and Procedures Natural Products Ask an Expert Support Groups Clinical Trials
Home Bookmark Page Send to a Friend Sante Chez Nous Subscribe
Drug Info > A > Apo-Medroxy
Please enter the drug name or
DIN (Drug Identification Number)


GoGO

Search by first letter

ABCDEFGHIJKLMNOPQRSTUVWXYZ

Brand Name

Apo-Medroxy

Common Name
medroxyprogesterone acetate


In this drug factsheet:



DIN (Drug Identification Number)

02267640 APO-MEDROXY 100 MG TABLET
02277298 APO-MEDROXY 10 MG TABLET
02244726 APO-MEDROXY 2.5 MG TABLET
02244727 APO-MEDROXY 5 MG TABLET

How does this medication work? What will it do for me?

Medroxyprogesterone belongs to the family of medications known as progesterones. Progesterones are female hormones. They are produced by the body and are necessary along with other hormones for normal female sexual development and for the regulation of the menstrual cycle during childbearing years. It reduces the effects of estrogen on tissues such as the endometrium (lining of the uterus) and the breast.

Medroxyprogesterone has a variety of uses. It is used in addition to postmenopausal estrogen replacement therapy (ERT) to prevent estrogen from thickening the lining of the uterus (endometrial hyperplasia). This significantly reduces the risk of endometrial cancer. It is also used to treat irregular menstrual cycles, lack of menstruation, and abnormal menstrual bleeding. Medroxyprogesterone is also used alone or in combination with other cancer medications to treat endometrial cancer and breast cancer.

This medication may be available under multiple brand names and/or in several different forms. Any specific brand name of this medication may not be available in all of the forms or approved for all of the conditions discussed here. As well, some forms of this medication may not be used for all of the conditions discussed here.

Your doctor may have suggested this medication for conditions other than those listed in these drug information articles. If you have not discussed this with your doctor or are not sure why you are taking this medication, speak to your doctor. Do not stop taking this medication without consulting your doctor.

Do not give this medication to anyone else, even if they have the same symptoms as you do. It can be harmful for people to take this medication if their doctor has not prescribed it.

How should I use this medication?

The recommended adult dose of medroxyprogesterone varies widely and depends on the condition being treated and the response to treatment.

For hormone replacement therapy, the dose ranges from 2.5 mg daily to 10 mg daily for several specific days of the month.

To control unusual and heavy bleeding of the uterus, or for treating unusual stopping of menstrual periods, a typical dose of medroxyprogesterone is 5 mg to 10 mg daily for 10 to 14 days per month.

A typical dose to treat breast cancer is 400 mg daily, and a typical dose for endometrial cancer treatment is 200 mg to 400 mg daily.

Many things can affect the dose of medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are taking the medication without consulting your doctor.

Unless medroxyprogesterone is being taken as part of breast cancer treatment, this medication should not be taken by women without an intact uterus.

Medroxyprogesterone may be taken with or without food.

It is important to take this medication exactly as prescribed by your doctor. If you miss a dose of medroxyprogesterone, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. If you are not sure what to do after missing a dose, contact your doctor or pharmacist for advice.

Store this medication in a dry place at room temperature, out of direct light, and keep it out of the reach of children.

Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.





What form(s) does this medication come in?

2.5 mg
Each round, pink-orange, biconvex tablet scored and marked "MED" over "2.5" on one side and "APO" on the other, contains 2.5 mg medroxyprogesterone acetate. Nonmedicinal ingredients: lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, sodium lauryl sulfate and colloidal silicon dioxide, D&C Yellow No. 10, and FD&C Yellow No. 6.

5 mg
Each round, blue, biconvex tablet scored and marked "MED" over "5" on one side and "APO" on the other, contains 5 mg medroxyprogesterone acetate. Nonmedicinal ingredients: lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, sodium lauryl sulfate and colloidal silicon dioxide, and FD&C Blue No. 2.

10 mg
Each round, white, biconvex tablet scored and marked "APO" over "10" on one side and plain on the other, contains 10 mg medroxyprogesterone acetate. Nonmedicinal ingredients: lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, sodium lauryl sulfate, and colloidal silicon dioxide.

100 mg
Each round, white, bevelled-edged tablet, scored and marked "MED" over "100" on one side and "APO" on the other, contains 100 mg medroxyprogesterone acetate. Nonmedicinal ingredients: lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, sodium lauryl sulfate, and colloidal silicon dioxide.

Who should NOT take this medication?

Do not take this medication if you:

  • are allergic to medroxyprogesterone or any ingredients of the medication
  • are pregnant
  • have certain blood clotting disorders or a history of these disorders (thrombophlebitis, thromboembolic disorders, cerebral apoplexy)
  • have known or suspected cancer dependent on hormones for growth
  • have liver disease
  • have loss of vision due to disease of the blood vessels of the eyes
  • have or have had breast cancer
  • have undiagnosed vaginal bleeding


 

Advertisement


Did you find what you were looking for on our website? Please let us know.


 Search for information related to
GO
ABCDEFGHIJKLMNOPQRSTUVWXYZ
 

Hot Topics - Bedwetting, Depression, Flu (Seasonal), Healthy Skin, Incontinence, Multiple Sclerosis, Psoriasis, Stroke Risk Reduction

Condition and disease information is written and reviewed by the MedBroadcast Clinical Team.


The contents of this site are for informational purposes only and are meant to be discussed with your physician or other qualified health care professional before being acted on. Never disregard any advice given to you by your doctor or other qualified health care professional. Always seek the advice of a physician or other licensed health care professional regarding any questions you have about your medical condition(s) and treatment(s). This site is not a substitute for medical advice.
© 1996 - 2014 MediResource Inc. - MediResource reaches millions of Canadians each year.